Na Selank

Na Selank (N-Acetyl Selank Amidate) is a stabilized synthetic analog of Selank, a heptapeptide derived from the endogenous tuftsin sequence. Structural modification enhances resistance to enzymatic degradation, allowing sustained evaluation in laboratory research models. In controlled experimental settings, Na Selank is investigated for its interaction with neuropeptide signaling and immune-regulatory pathways, including modulation of GABAergic transmission and cytokine-associated signaling mechanisms.

In vitro systems and structured clinical investigations evaluate endpoints including GABA receptor-associated signaling markers, brain-derived neurotrophic factor (BDNF) expression levels, IL-6-related cytokine pathway activity, monoamine-associated signaling profiles, and transcriptional changes linked to stress-response regulation relative to controls. Additional research explores neuroimmune cross-talk mechanisms, synaptic plasticity markers, and peptide-mediated modulation of inflammatory signaling cascades within defined neurobiology frameworks.